Envoy Medical
COCH
9 hedge funds and large institutions have $3.02M invested in Envoy Medical in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 10 closing their positions.
44% less funds holding
Funds holding: 16 → 9 (-7)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
61.25% less ownership
Funds ownership: 69.68% → 8.44% (-61%)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
88% less capital invested
Capital invested by funds: $24.9M → $3.02M (-$21.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$83.6K |
| 2 |
Morgan Stanley
New York
|
+$11K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.36K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$106 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Sandia Investment Management
Boston,
Massachusetts
|
-$5.21M |
| 2 |
FTCM
Fir Tree Capital Management
New York
|
-$2.56M |
| 3 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
-$1.13M |
| 4 |
CS
Clear Street
New York
|
-$891K |
| 5 |
RCM
Robinson Capital Management
Grosse Pointe Farms,
Michigan
|
-$891K |
COCH Hedge Fund Activity: Q4 2023 in Review
9 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2023, worth a combined $3.02M — down 88% from $24.9M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of COCH and 3 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Geode Capital Management, adding an estimated $83.6K. The largest seller was Sandia Investment Management, exiting entirely with an estimated $5.21M sold.
- 9 institutional investors held Envoy Medical (COCH) as of Q4 2023, down from 16 in Q3 2023.
- Funds reported $3.02M of Envoy Medical stock for Q4 2023, down 88% quarter-over-quarter.
- 3 funds opened new Envoy Medical positions in Q4 2023 and 10 closed out, a net change of -7 holders.
- The largest Envoy Medical buyer in Q4 2023 was Geode Capital Management, an estimated $83.6K added.
- The largest Envoy Medical seller in Q4 2023 was Sandia Investment Management, an estimated $5.21M sold.
Based on aggregated 13F filings for Q4 2023.